Surrogate outcomes in health technology assessment: an international comparison. - Wikidata - awgldk - TriplyDB

Surrogate outcomes in health technology assessment: an international comparison.

Surrogate outcomes in health technology assessment: an international comparison.

http://www.wikidata.org/entity/Q37556678

about

Time-dependent endpoints as predictors of overall survival in multiple myeloma Outcomes in registered, ongoing randomized controlled trials of patient education.The role of health technology assessment bodies in shaping drug development.Personalizing health care: feasibility and future implications.Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways Surrogate outcomes: experiences at the Common Drug Review.Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers.Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses.The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate.

P2860

Q30538040-07A5BC06-82FA-4DAF-A0D8-F39D0BE9C650 Q34391137-7206FA34-F297-4B0E-A86B-1F328D207ED7 Q34524056-464BB2D7-6347-4AED-8377-46C286334489 Q34938911-2D0B939C-2B1C-4A5A-AD8B-CFEEC4DB230A Q37290101-E16132D2-97C5-41D9-93F0-929BA1C0910C Q37400903-598AB540-39AB-40A2-B387-B77213CC9823 Q38259501-3B18DF44-9D9A-4A0A-8913-0948FE1D16A0 Q45339505-99E19E98-D3CC-450B-B93A-7381721677D0 Q48375673-4336B71A-D5CB-4231-8DD4-0871D43BD938

P2860

Surrogate outcomes in health technology assessment: an international comparison.

http://www.wikidata.org/entity/Q37556678

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Surrogate outcomes in health technology assessment: an international comparison.

@en

Surrogate outcomes in health technology assessment: an international comparison.

@nl

type

label

Surrogate outcomes in health technology assessment: an international comparison.

@en

Surrogate outcomes in health technology assessment: an international comparison.

@nl

prefLabel

Surrogate outcomes in health technology assessment: an international comparison.

@en

Surrogate outcomes in health technology assessment: an international comparison.

@nl

P1433

Q37556678-E4E49B19-3892-47CD-8297-9EF8D5834010

P1476

Q37556678-55FE44B3-E349-43BD-9BEA-87FC48050147

P2093

Q37556678-E1D56A05-348B-4581-A38E-2A45C9BAE872

Q37556678-E4D5CF46-70D8-480F-9FE5-319ADE3113EC

P2860

Q37556678-21B2205D-DAAE-42E7-BCD6-BE7931E49AF9

Q37556678-2B25CE8C-CD99-41D4-AEBD-04CDD86A7B8C

Q37556678-36657652-C9DE-4513-9865-0833463BA9F9

Q37556678-4C2C37F3-E0BA-4FD5-8EEA-3E53AA2B2C4B

Q37556678-872E297B-5D37-4356-B794-2C52BC747754

Q37556678-A80C862D-19AD-410E-BE25-860DC171121E

Q37556678-AA4294B2-9D88-4D68-AB09-516C5CC72041

Q37556678-DA046CDA-F4B3-4F28-8847-F28478FF90A1

P304

Q37556678-A2B47DFF-1EE0-4AAB-B44C-D84DDDD91286

P31

Q37556678-D3F60A24-FC93-498F-8C3D-DF90B5CDCC86

P356

Q37556678-0CCE7446-346F-4BBA-B7F8-532A890AD90F

P433

Q37556678-88CFD8B8-20F1-4D71-902C-5E5EFF38976E

P478

Q37556678-011B8887-19FE-4216-B68C-DEFF81A14F27

P577

Q37556678-6CF7F9BB-1E8E-46C2-B27D-252DF1AA5A11

P698

Q37556678-A644635E-1E93-4CCE-9A80-BD481F8F1629

P356

S0266462309990213

P1433

International Journal of Technology Assessment in Health Care

P1476

Surrogate outcomes in health technology assessment: an international comparison.

@en

P2093

Marcial Velasco Garrido

http://www.w3.org/2001/XMLSchema#string

Sandra Mangiapane

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

International comparison of the definition and the practical application of health technology assessment.

Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation.

Use of surrogate outcomes in cost-effectiveness models: a review of United Kingdom health technology assessment reports.

Surrogate end points in clinical trials: are we being misled?

The efficacy of diagnostic imaging.

P304

315-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0266462309990213

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19619350

http://www.w3.org/2001/XMLSchema#string